Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).
- Resource Type
- journal article
- Source
- Medical Oncology; Aug2022, Vol. 39 Issue 8, p1-9, 9p
- Subject
- Language
- ISSN
- 13570560